A new recombinant MS-superoxide dismutase alleviates 5-fluorouracil-induced intestinal mucositis in mice

[1]  Hailian Shi,et al.  Alteration of Gut Microbiota and Inflammatory Cytokine/Chemokine Profiles in 5-Fluorouracil Induced Intestinal Mucositis , 2017, Front. Cell. Infect. Microbiol..

[2]  K. Higuchi,et al.  Apoptosis, Dysbiosis and Expression of Inflammatory Cytokines are Sequential Events in the Development of 5‐Fluorouracil‐Induced Intestinal Mucositis in Mice , 2017, Basic & clinical pharmacology & toxicology.

[3]  B. Deng,et al.  Efficacy of long-acting release octreotide for preventing chemotherapy-induced diarrhoea: protocol for a systematic review , 2017, BMJ Open.

[4]  M. Narita,et al.  Curcumin Inhibits 5‐Fluorouracil‐induced Up‐regulation of CXCL1 and CXCL2 of the Colon Associated with Attenuation of Diarrhoea Development , 2016, Basic & clinical pharmacology & toxicology.

[5]  Linshu Jiang,et al.  Punicalagin induces Nrf2 translocation and HO-1 expression via PI3K/Akt, protecting rat intestinal epithelial cells from oxidative stress , 2016, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[6]  Guoyao Wu,et al.  Autophagy and tight junction proteins in the intestine and intestinal diseases , 2015, Animal nutrition.

[7]  Nastaran Razavi,et al.  The Role of Interleukin (IL-22) in immune response to human diseases , 2015 .

[8]  J. Schulzke,et al.  Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation , 2015, Tissue barriers.

[9]  F. D. De Braud,et al.  Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5-fluorouracil: a meta-analysis of published trials. , 2014, British journal of clinical pharmacology.

[10]  Clifton D Fuller,et al.  Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: A prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory‐Head and Neck Module , 2014, Cancer.

[11]  L. D. Goldberg,et al.  A single center, pilot, double-blinded, randomized, comparative, prospective clinical study to evaluate improvements in the structure and function of facial skin with tazarotene 0.1% cream alone and in combination with GliSODin® Skin Nutrients Advanced Anti-Aging Formula , 2014, Clinical, cosmetic and investigational dermatology.

[12]  S. Mitra,et al.  Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. , 2014, Physiological reviews.

[13]  Jian Fei,et al.  Chimonanthus nitens var. salicifolius Aqueous Extract Protects against 5-Fluorouracil Induced Gastrointestinal Mucositis in a Mouse Model , 2013, Evidence-based complementary and alternative medicine : eCAM.

[14]  R. Klopfleisch,et al.  Commensal Akkermansia muciniphila Exacerbates Gut Inflammation in Salmonella Typhimurium-Infected Gnotobiotic Mice , 2013, PloS one.

[15]  S. Mani,et al.  Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis. , 2013, Current drug targets.

[16]  K. Takeuchi,et al.  5‐HT3 receptor antagonists ameliorate 5‐fluorouracil‐induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cells , 2013, British journal of pharmacology.

[17]  Yan Lin,et al.  IL-17/IFN-γ interactions regulate intestinal inflammation in TNBS-induced acute colitis. , 2012, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[18]  U. Förstermann,et al.  Nitric oxide synthases: regulation and function. , 2012, European heart journal.

[19]  S. Sukumar,et al.  Loperamide, an FDA-Approved Antidiarrhea Drug, Effectively Reverses the Resistance of Multidrug Resistant MCF-7/MDR1 Human Breast Cancer Cells to Doxorubicin-Induced Cytotoxicity , 2012, Cancer investigation.

[20]  B. Aggarwal,et al.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach. , 2011, Current drug targets.

[21]  C. Weber,et al.  Occludin is Required for Tumor Necrosis Factor (TNF)-Mediated Regulation of Tight Junction (TJ) Barrier Function , 2011 .

[22]  D. Ye,et al.  Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrier. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[23]  F. Gao,et al.  Effect of histamine-2-receptor antagonists versus sucralfate on stress ulcer prophylaxis in mechanically ventilated patients: a meta-analysis of 10 randomized controlled trials , 2010, Critical care.

[24]  C. Feinle-Bisset,et al.  The herbal extract Iberogast® improves jejunal integrity in rats with 5-Fluorouracil (5-FU)-induced mucositis , 2009, Cancer biology & therapy.

[25]  H. Clevers,et al.  Stem cells, self-renewal, and differentiation in the intestinal epithelium. , 2009, Annual review of physiology.

[26]  Kenji Suzuki,et al.  Is there a link between food and intestinal microbes and the occurrence of Crohn's disease and ulcerative colitis? , 2008, Journal of gastroenterology and hepatology.

[27]  M. Kay,et al.  Radioprotection in vitro and in vivo by minicircle plasmid carrying the human manganese superoxide dismutase transgene. , 2008, Human gene therapy.

[28]  D. Harris.  Cancer Treatment-Induced Mucositis Pain: Strategies for Assessment and Management , 2006, Therapeutics and clinical risk management.

[29]  Hongfei Zhou,et al.  Anti-inflammatory properties of a chimeric recombinant superoxide dismutase: SOD2/3. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[30]  S. Sonis.  The pathobiology of mucositis , 2004, Nature Reviews Cancer.

[31]  P. Johnston,et al.  5-Fluorouracil: mechanisms of action and clinical strategies , 2003, Nature Reviews Cancer.

[32]  T. Andersson,et al.  Treatment of traumatic arthritis in the horse with intra-articular orgotein (palosein). , 1978, Equine veterinary journal.

[33]  C. N. Coleman,et al.  Intrarectal amifostine during external beam radiation therapy for prostate cancer produces significant improvements in Quality of Life measured by EPIC score. , 2008, International journal of radiation oncology, biology, physics.